domingo, 4 de diciembre de 2016

Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects. - PubMed - NCBI

Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects. - PubMed - NCBI
 2016 Nov 28. [Epub ahead of print]

Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.

Abstract

The genome of two completely unrelated individuals is quite similar apart from minor variations called single nucleotide polymorphisms which contribute to the uniqueness of each and every person. These single nucleotide polymorphisms are of great interest clinically as they are useful in figuring out the susceptibility of certain individuals to particular diseases and for recognizing varied responses to pharmacological interventions. This gives rise to the idea of 'personalized medicine' as an exciting new therapeutic science in this genomic era. Personalized medicine suggests a unique treatment strategy based on an individual's genetic make-up. Its key principles revolve around applied pharmaco-genomics, pharmaco-kinetics and pharmaco-proteomics. Herein, the ethical and legal aspects of personalized medicine in a new genomic era are briefly addressed. The ultimate goal is to comprehensively recognize all relevant forms of genetic variation in each individual and be able to interpret this information in a clinically meaningful manner within the ambit of ethical and legal considerations. The authors of this article firmly believe that personalized medicine has the potential to revolutionize the current landscape of medicine as it makes its way into clinical practice.

KEYWORDS:

Ethical and legal aspects; Genomic era; Personalized medicine
PMID:
 
27896605
 
DOI:
 
10.1007/s11948-016-9828-4
[PubMed - as supplied by publisher]

No hay comentarios: